Latest Blogs, Articles, and More View More >>
View More >>
It is known that the fertility of adolescent and young adult patients with cancer can be put at risk by treatments, but little research has been conducted looking at awareness, counseling and actions in this area.
Deciding how to approach a cancer anniversary can be exciting, scary or maybe just somewhere in between.
Understanding how the immune system controls itself has led to advances in immunotherapy.
Patient success stories illustrate the hope promised by cancer immunotherapy.
Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.
Continuing Avastin (bevacizumab) in patients with recurrent glioblastoma after progression of the disease does not improve patient outcomes, according to results from the phase 2 CABARET trial.
An analysis of three interrelated biomarkers in high-risk low-grade glioma (LGG) has identified distinct risk groups by isocitrate dehydrogenase (IDH) mutation status and suggested appropriate treatment strategies.